SCHEMBL25375889

SCHEMBL25375889

C=Cc1ccc(-c2cccnc2Nc2ccc(C(F)(F)F)cc2)cn1

nearest known ligand 0.44

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 7/20 0.44
▸ TRPV1 Q8NER1 11/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25376142 0.86 EPHX2 (0.45) EPHX2TRPV1
SCHEMBL25374304 0.83 TRPV1 (0.42) EPHX2TRPV1
SCHEMBL30482578 0.83 TRPV1 (0.42) EPHX2TRPV1
SCHEMBL25376256 0.82 KCNQ3 (0.48) EPHX2TRPV1
SCHEMBL25376170 0.78 FEN1 (0.42) —
SCHEMBL25974049 0.77 EPHX2 (0.42) EPHX2TRPV1
SCHEMBL25341145 0.77 EPHX2 (0.42) EPHX2TRPV1
SCHEMBL25378193 0.77 ABCG2 (0.47) EPHX2TRPV1
SCHEMBL25341064 0.76 TRPV1 (0.50) EPHX2TRPV1
SCHEMBL25341133 0.75 MKNK1 (0.51) EPHX2TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146512-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
WO-2023146512-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback